Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - Theravance Biopharma, Inc. | a2223389zex-32.htm |
| EX-31.2 - EX-31.2 - Theravance Biopharma, Inc. | a2223389zex-31_2.htm |
| EX-23.1 - EX-23.1 - Theravance Biopharma, Inc. | a2223389zex-23_1.htm |
| EX-10.39 - EX-10.39 - Theravance Biopharma, Inc. | a2223389zex-10_39.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Theravance Biopharma, Inc. | Financial_Report.xls |
| 10-K - 10-K - Theravance Biopharma, Inc. | a2223389z10-k.htm |
| EX-31.1 - EX-31.1 - Theravance Biopharma, Inc. | a2223389zex-31_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Theravance
Biopharma US, Inc. (Delaware)
Theravance Biopharma Antibiotics, Inc. (Cayman Islands)
Theravance Biopharma R&D, Inc. (Cayman Islands)
Theravance Biopharma UK Limited (England and Wales)
Subsidiaries